Skip to content

Achieving Portal Access With Scorpion Post-Approval Study 2

A Retrospective Data Collection Evaluating Portal Vein Access Sets For Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06856655
Acronym
APASS2
Enrollment
82
Registered
2025-03-04
Start date
2022-02-01
Completion date
2024-03-28
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascites Hepatic, Hydrothorax, Liver Diseases, Portal Hypertension, Vascular Diseases

Keywords

Transjugular Intrahepatic Portosystemic Shunt, TIPS, Portal Vein Access

Brief summary

Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.

Interventions

Procedure/Surgery: Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Sponsors

Argon Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1\. Scorpion or Scorpion X kit introduced into the vasculature as the initial device for portal vein access

Exclusion criteria

1. TIPS procedure was not initiated and/or no portion of the kit was introduced into the vasculature 2. Inaccessible medical records

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Technical SuccessTIPS ProcedureCreation of the parenchymal tract between the hepatic vein and an intrahepatic branch of the portal vein and confirmed by portogram
Composite of Major ComplicationsThrough 30 days post-TIPS procedureMajor complications associated with the procedure or study device and defined as complications resulting in an unplanned increase in the level of care, prolonged hospitalization, permanent adverse sequelae, or death.

Secondary

MeasureTime frameDescription
Number of Participants with Procedural SuccessTIPS ProcedureSuccessful delivery of the shunt
Device-Related ComplicationsThrough 30 days post-TIPS procedureIncidence of complications related to the device as judged by the Investigator

Other

MeasureTime frameDescription
Portal Vein Access (PVA) TimeTIPS ProcedureTime (in minutes) from hepatic vein access to portal vein access
Change in Child-Pugh scoreup to 30 days post-TIPs procedureChange in score from Baseline Characteristics to Follow Up Data
Procedure durationTIPS ProcedureInterval (in minutes) from first jugular access for TIPS creation to removal of catheters from subject
Fluoroscopy TimeTIPS ProcedureMeasured in minutes
Change in MELD scoreup to 30 days post-TIPs procedureChange in score from Baseline Characteristics to Follow Up Data

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026